Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
C$10.64
+0.1%
C$10.18
C$7.79
C$10.94
C$1.93B1.2555,544 shs580,767 shs
Equinox Gold Corp. stock logo
EQX
Equinox Gold
$5.38
-1.3%
$0.00
$3.95
$6.50
$2.08B1.334.88 million shs1.75 million shs
NGD
New Gold
$1.81
-0.5%
$0.00
$0.86
$1.95
$1.25B1.538.97 million shs3.64 million shs
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
$67.50
+1.2%
$64.85
$58.73
$88.26
$4.08B0.48558,995 shs277,926 shs
10x Genomics, Inc. stock logo
TXG
10x Genomics
$27.48
+4.5%
$35.81
$24.60
$63.57
$3.27B1.941.97 million shs2.39 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
+0.09%-1.48%+3.50%+23.86%+4.01%
Equinox Gold Corp. stock logo
EQX
Equinox Gold
0.00%0.00%0.00%-2.05%-22.34%
NGD
New Gold
-0.55%+71.56%+71.56%+71.56%+27.46%
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
+1.18%+6.97%+4.88%+2.97%-19.44%
10x Genomics, Inc. stock logo
TXG
10x Genomics
+4.53%-0.40%-24.40%-36.97%-49.11%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
4.1713 of 5 stars
3.50.01.70.03.42.52.5
Equinox Gold Corp. stock logo
EQX
Equinox Gold
1.6631 of 5 stars
0.01.00.00.03.30.03.8
NGD
New Gold
2.2389 of 5 stars
1.05.00.00.03.30.83.1
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
4.3923 of 5 stars
2.34.01.74.51.32.51.9
10x Genomics, Inc. stock logo
TXG
10x Genomics
4.4302 of 5 stars
4.31.00.04.81.63.30.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
3.00
BuyC$13.7829.52% Upside
Equinox Gold Corp. stock logo
EQX
Equinox Gold
2.50
Moderate BuyN/AN/A
NGD
New Gold
2.00
Hold$1.64-9.39% Downside
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
2.50
Moderate Buy$81.0020.00% Upside
10x Genomics, Inc. stock logo
TXG
10x Genomics
2.58
Moderate Buy$48.5076.49% Upside

Current Analyst Ratings

Latest DPM, EQX, NGD, ORA, and TXG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/2/2024
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetC$13.25 ➝ C$14.00
5/1/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$52.00 ➝ $30.00
5/1/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSell ➝ Sell$30.00 ➝ $26.00
5/1/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$45.00 ➝ $36.00
5/1/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$63.00 ➝ $53.00
5/1/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$57.00 ➝ $32.00
4/29/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$65.00 ➝ $50.00
4/26/2024
Equinox Gold Corp. stock logo
EQX
Equinox Gold
National Bank Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Perform Spec Overwgt ➝ Outperform Overweight
4/23/2024
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetC$13.00 ➝ C$13.25
4/19/2024
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetC$14.00 ➝ C$13.50
4/19/2024
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetC$13.00 ➝ C$14.50
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
C$520.09M3.71C$3.82 per share2.79C$6.18 per share1.72
Equinox Gold Corp. stock logo
EQX
Equinox Gold
$1.09B1.91$0.74 per share7.29$7.68 per share0.70
NGD
New Gold
$786.50M1.59$0.41 per share4.41$1.07 per share1.69
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
$829.42M4.92$5.81 per share11.61$40.44 per share1.67
10x Genomics, Inc. stock logo
TXG
10x Genomics
$618.73M5.29N/AN/A$6.03 per share4.56

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
C$181.98MC$1.338.000.0437.10%17.22%9.53%5/7/2024 (Confirmed)
Equinox Gold Corp. stock logo
EQX
Equinox Gold
$28.88M$0.0959.786.90N/A2.65%0.69%0.40%N/A
NGD
New Gold
-$64.50M-$0.10N/A12.070.57-9.81%5.23%1.91%N/A
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
$124.40M$2.0932.3028.853.1215.00%5.09%2.41%5/8/2024 (Confirmed)
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$255.10M-$2.23N/AN/AN/A-42.20%-30.85%-24.17%8/1/2024 (Estimated)

Latest DPM, EQX, NGD, ORA, and TXG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
$0.68N/A-$0.68N/AN/AN/A  
5/7/2024N/A
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
C$0.27N/A-C$0.27N/AN/AN/A
4/30/2024Q1 2024
NGD
New Gold
$0.01$0.02+$0.01$0.10N/A$192.10 million    
4/30/2024Q1 2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$0.50-$0.50N/A-$0.50$142.24 million$141.01 million    
2/21/202412/31/2023
Equinox Gold Corp. stock logo
EQX
Equinox Gold
-$0.02$0.01+$0.03$0.01N/A$297.80 million    
2/21/2024Q4 2023
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
$0.60$0.67+$0.07$0.75$239.71 million$241.30 million    
2/15/2024Q4 2023
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$0.36-$0.41-$0.05-$0.41$182.73 million$183.98 million    
2/14/2024Q4 2023
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
C$0.48C$0.38-C$0.10C$0.32N/AC$189.66 million
2/13/2024Q4 2023
NGD
New Gold
$0.02-$0.01-$0.03$0.02N/A$199.20 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
C$0.222.07%N/A16.54%N/A
Equinox Gold Corp. stock logo
EQX
Equinox Gold
N/AN/AN/AN/AN/A
NGD
New Gold
N/AN/AN/AN/AN/A
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
$0.480.71%+2.94%22.97%N/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A

Latest DPM, EQX, NGD, ORA, and TXG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/14/2024
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
QuarterlyC$0.052.57%3/27/20243/31/20244/15/2024
2/21/2024
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
Quarterly$0.120.75%3/5/20243/6/20243/20/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
0.28
6.70
6.61
Equinox Gold Corp. stock logo
EQX
Equinox Gold
0.32
1.74
0.88
NGD
New Gold
0.54
1.51
0.98
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
0.64
1.20
1.12
10x Genomics, Inc. stock logo
TXG
10x Genomics
N/A
5.22
4.11

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
63.89%
Equinox Gold Corp. stock logo
EQX
Equinox Gold
38.85%
NGD
New Gold
42.82%
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
95.49%
10x Genomics, Inc. stock logo
TXG
10x Genomics
84.68%

Insider Ownership

CompanyInsider Ownership
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
0.11%
Equinox Gold Corp. stock logo
EQX
Equinox Gold
8.35%
NGD
New Gold
0.20%
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
1.00%
10x Genomics, Inc. stock logo
TXG
10x Genomics
10.65%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Dundee Precious Metals Inc. stock logo
DPM
Dundee Precious Metals
147,000181.43 millionN/ANot Optionable
Equinox Gold Corp. stock logo
EQX
Equinox Gold
3,692386.22 million353.97 millionNot Optionable
NGD
New Gold
1,578689.83 million688.45 millionN/A
Ormat Technologies, Inc. stock logo
ORA
Ormat Technologies
1,57660.40 million59.80 millionOptionable
10x Genomics, Inc. stock logo
TXG
10x Genomics
1,259119.17 million106.48 millionOptionable

DPM, EQX, NGD, ORA, and TXG Headlines

SourceHeadline
Research Analysts Issue Forecasts for 10x Genomics, Inc.s Q2 2024 Earnings (NASDAQ:TXG)Research Analysts Issue Forecasts for 10x Genomics, Inc.'s Q2 2024 Earnings (NASDAQ:TXG)
americanbankingnews.com - May 4 at 1:42 AM
Q2 2024 Earnings Estimate for 10x Genomics, Inc. Issued By William Blair (NASDAQ:TXG)Q2 2024 Earnings Estimate for 10x Genomics, Inc. Issued By William Blair (NASDAQ:TXG)
marketbeat.com - May 3 at 7:28 AM
10x Genomics (NASDAQ:TXG) PT Lowered to $36.0010x Genomics (NASDAQ:TXG) PT Lowered to $36.00
americanbankingnews.com - May 3 at 5:14 AM
10x Genomics (NASDAQ:TXG) Stock Rating Lowered by TD Cowen10x Genomics (NASDAQ:TXG) Stock Rating Lowered by TD Cowen
americanbankingnews.com - May 3 at 5:14 AM
The Goldman Sachs Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $26.00The Goldman Sachs Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $26.00
americanbankingnews.com - May 3 at 5:14 AM
Stifel Nicolaus Lowers 10x Genomics (NASDAQ:TXG) Price Target to $53.00Stifel Nicolaus Lowers 10x Genomics (NASDAQ:TXG) Price Target to $53.00
americanbankingnews.com - May 3 at 5:14 AM
10x Genomics (NASDAQ:TXG) PT Lowered to $30.0010x Genomics (NASDAQ:TXG) PT Lowered to $30.00
americanbankingnews.com - May 3 at 5:14 AM
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference10x Genomics to Present at the BofA Securities 2024 Healthcare Conference
prnewswire.com - May 2 at 4:05 PM
TD Cowen Downgrades 10x Genomics (TXG)TD Cowen Downgrades 10x Genomics (TXG)
msn.com - May 2 at 7:37 AM
10x Genomics First Quarter 2024 Earnings: In Line With Expectations10x Genomics First Quarter 2024 Earnings: In Line With Expectations
finance.yahoo.com - May 2 at 7:37 AM
10x Genomics, Inc: 10x Genomics Reports First Quarter 2024 Financial Results10x Genomics, Inc: 10x Genomics Reports First Quarter 2024 Financial Results
finanznachrichten.de - May 2 at 2:37 AM
10x Genomics (NASDAQ:TXG) Sets New 12-Month Low After Analyst Downgrade10x Genomics (NASDAQ:TXG) Sets New 12-Month Low After Analyst Downgrade
americanbankingnews.com - May 2 at 1:18 AM
10x Genomics (NASDAQ:TXG) Given New $30.00 Price Target at UBS Group10x Genomics (NASDAQ:TXG) Given New $30.00 Price Target at UBS Group
marketbeat.com - May 1 at 2:32 PM
10x Genomics (NASDAQ:TXG) Hits New 12-Month Low After Analyst Downgrade10x Genomics (NASDAQ:TXG) Hits New 12-Month Low After Analyst Downgrade
marketbeat.com - May 1 at 11:34 AM
Analysts’ Opinions Are Mixed on These Healthcare Stocks: 10x Genomics (TXG), Zoetis (ZTS) and Blueprint Medicines (BPMC)Analysts’ Opinions Are Mixed on These Healthcare Stocks: 10x Genomics (TXG), Zoetis (ZTS) and Blueprint Medicines (BPMC)
markets.businessinsider.com - May 1 at 8:41 AM
10x Genomics (NASDAQ:TXG) Downgraded by TD Cowen10x Genomics (NASDAQ:TXG) Downgraded by TD Cowen
marketbeat.com - May 1 at 8:32 AM
Canaccord Genuity Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $50.00Canaccord Genuity Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $50.00
americanbankingnews.com - May 1 at 5:32 AM
10x Genomics Inc (TXG) (Q1 2024) Earnings Call Transcript Highlights: Diverse Revenue Streams ...10x Genomics Inc (TXG) (Q1 2024) Earnings Call Transcript Highlights: Diverse Revenue Streams ...
finance.yahoo.com - May 1 at 3:41 AM
Curio Bioscience Reports Clarifying Decision From European Unified Patent Court (UPC)Curio Bioscience Reports Clarifying Decision From European Unified Patent Court (UPC)
businesswire.com - May 1 at 1:01 AM
10x Genomics: Q1 Earnings Snapshot10x Genomics: Q1 Earnings Snapshot
sfgate.com - April 30 at 10:41 PM
TXG Stock Earnings: 10x Genomics Meets EPS, Misses Revenue for Q1 2024TXG Stock Earnings: 10x Genomics Meets EPS, Misses Revenue for Q1 2024
markets.businessinsider.com - April 30 at 10:41 PM
10x Genomics (TXG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates10x Genomics (TXG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com - April 30 at 7:31 PM
10x Genomics Inc (TXG) Q1 2024 Earnings: Misses Analyst Expectations Amidst New Product Launches10x Genomics Inc (TXG) Q1 2024 Earnings: Misses Analyst Expectations Amidst New Product Launches
finance.yahoo.com - April 30 at 6:17 PM
10x Genomics (NASDAQ:TXG) Releases  Earnings Results, Misses Estimates By $0.04 EPS10x Genomics (NASDAQ:TXG) Releases Earnings Results, Misses Estimates By $0.04 EPS
marketbeat.com - April 30 at 5:08 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Dundee Precious Metals logo

Dundee Precious Metals

TSE:DPM
Dundee Precious Metals Inc., a gold mining company, engages in the acquisition, exploration, development, mining, and processing of precious metals. The company primarily explores for gold, copper, and silver deposits. It holds a portfolio of projects located in Bulgaria, Namibia, Serbia, and Ecuador. The company is based in Toronto, Canada.
Equinox Gold logo

Equinox Gold

NYSEAMERICAN:EQX
Equinox Gold Corp. engages in the exploration, acquisition, development, and operation of mineral properties in the Americas. It explores gold and silver deposits. It holds interest in properties in California located in the United States; Guerrero State located in Mexico; Maranhão, Bahia, and Mina Gerais state located in Brazil; and Ontario, Canada. The company was formerly known as Trek Mining Inc. and changed its name to Equinox Gold Corp. in December 2017. Equinox Gold Corp. was incorporated in 2007 and is headquartered in Vancouver, Canada.

New Gold

NYSE:NGD
New Gold Inc., an intermediate gold mining company, develops and operates of mineral properties in Canada. It primarily explores for gold, silver, and copper deposits. The company's principal operating properties include 100% interest in the Rainy River mine located in Northwestern Ontario, Canada; and New Afton project situated in South-Central British Columbia. New Gold Inc. is headquartered in Toronto, Canada.
Ormat Technologies logo

Ormat Technologies

NYSE:ORA
Ormat Technologies, Inc. engages in the geothermal and recovered energy power business in the United States, Indonesia, Kenya, Turkey, Chile, Guatemala, Guadeloupe, New Zealand, Honduras, and internationally. It operates in three segments: Electricity, Product, and Energy Storage. The Electricity segment develops, builds, owns, and operates geothermal, solar photovoltaic, and recovered energy-based power plants; and sells electricity. The Product segment designs, manufactures, and sells equipment for geothermal and recovered energy-based electricity generation; and provides services relating to the engineering, procurement, construction, operation, and maintenance of geothermal and recovered energy-based power plants. This segment serves contractors; and owners and operators of interstate natural gas pipelines, gas processing plants, and cement plants, as well as companies in other energy-intensive industrial processes. The Energy Storage segment offers battery energy storage systems and related services. Ormat Technologies, Inc. was founded in 1965 and is headquartered in Reno, Nevada.
10x Genomics logo

10x Genomics

NASDAQ:TXG
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.